Magrath Regimen

Preferred Label : Magrath Regimen;

NCIt related terms : Magrath Protocol;

NCIt definition : A regimen consisting of cyclophosphamide, vincristine, doxorubicin, prednisone, and high-dose methotrexate used to treat aggressive forms of non-Hodgkin lymphoma; also used as primary treatment of AIDS-related and high-risk Burkitt's lymphoma. Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.;

NCIt note : Source: Physician's Cancer Chemotherapy Drug Manual 2006;

Détails

Origin ID

C63780;

UMLS CUI

C1881510;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Cytarabine [NCIt concept]
- Doxorubicin [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Methotrexate [NCIt concept]
- Prednisone [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]
regimen_has_accepted_use_for_disease
- AIDS-Related Non-Hodgkin Lymphoma [NCIt concept]
- Adult Burkitt Lymphoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients